💊 Update: Changes to Ribociclib (Kisqali) Storage & Packaging

We wanted to share an important update for anyone currently taking ribociclib (Kisqali), a targeted therapy used for HR-positive, HER2-negative breast cancer (early or advanced), often alongside hormone therapy.

🔄What’s changed? 
From early May, ribociclib tablets no longer need to be stored in the fridge. They can now be kept at room temperature (below 30°C).

📦During the transition period 

• Some packs will still have the old refrigeration instructions
• Others will reflect the new room temperature guidance
• You may notice changes to packaging, including:
• A longer expiry date (up to 24 months)
• Different blister pack sizes
• A new layout showing how many tablets to take each day

💡Why the change? 
The medication itself has not changed. Updates to manufacturing and packaging now allow the tablets to be stored safely at room temperature. Because of this transition, both “old” (refrigerated) and “new” packs will be in circulation for a while.

 ✅What do you need to do? 

• Always follow the storage instructions on your specific pack
• If your pack says to refrigerate, continue to do so until it’s finished
• Don’t be concerned if packaging looks different, the medicine remains the same
• Speak to your healthcare team if you have any questions or concerns

For more information check out the following resources

👉Early breast cancer

👉Metastatic breast cancer

As always, we’re here to support you. If you’ve noticed these changes or want to share your experience, please call our Helpline on 1800 500 258 Monday-Friday 9am-5pm